TELZIR 700 MG
FOSAMPRENAVIR (FOSAMPRENAVIR CALCIUM) : 700 MG · DIN 02261545 · VIIV HEALTHCARE ULC
Health Canada status: CANCELLED POST MARKET
What is TELZIR?
TELZIR 700 MG contains FOSAMPRENAVIR (FOSAMPRENAVIR CALCIUM) : 700 MG. It is listed in the Health Canada Drug Product Database under DIN 02261545, held by VIIV HEALTHCARE ULC, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 31-Dec-2024. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is TELZIR used for?
TELZIR (fosamprenavir calcium) in combination with low-dose ritonavir is indicated for the treatment of HIV-1 infection in adults and pediatric patients ≥ 6 years old, in combination with other antiretroviral agents.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02261545 |
|---|---|
| Brand name | TELZIR |
| Generic / active ingredient | FOSAMPRENAVIR (FOSAMPRENAVIR CALCIUM) : 700 MG |
| Manufacturer | VIIV HEALTHCARE ULC |
| Strength | 700 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | J05AE07 FOSAMPRENAVIR |
| AHFS class | 08:18.08.08 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 31-Dec-2024 |
| Original market date | 2005-02-23 00:00:00 |
How is it stored and handled?
null
How is it supplied?
null
What can be used instead?
Other Canadian products sharing ATC code J05AE07 FOSAMPRENAVIR. 0 of 2 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| TELZIR | 50 MG | SUSPENSION | VIIV HEALTHCARE ULC | CANCELLED POST MARKET | DIN 02261553 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.